Referințe:
^{1 Welch HG, et al. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. J Natl Cancer Inst. 2007
2 Pinsky PF, et al. Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial. BJU Int. 2007
3 96% NPV for high-grade cancer. Van Neste L, et al. Risk score predicts highgrade prostate cancer in DNA-methylation positive, histopathologically negative biopsies. Prostate. 2016
4 Partin AW, et al. J Uro. 2014.
5 Stewart G, et al. J Uro. 2013.
6 Van Neste L, et al. Prostate. 2016
7 Waterhouse RL Jr, et al. Urology. 2018.}